Logo image of KOVO.CA

KOVO+ HOLDINGS INC (KOVO.CA) Stock Fundamental Analysis

Canada - TSX-V:KOVO - CA5007421012 - Common Stock

0.04 CAD
+0 (+14.29%)
Last: 10/29/2025, 7:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to KOVO. KOVO was compared to 8 industry peers in the Health Care Technology industry. KOVO has a bad profitability rating. Also its financial health evaluation is rather negative. KOVO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year KOVO has reported negative net income.
KOVO had a negative operating cash flow in the past year.
KOVO.CA Yearly Net Income VS EBIT VS OCF VS FCFKOVO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

KOVO has a Return On Assets of -46.90%. This is in the better half of the industry: KOVO outperforms 62.50% of its industry peers.
Industry RankSector Rank
ROA -46.9%
ROE N/A
ROIC N/A
ROA(3y)-35.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KOVO.CA Yearly ROA, ROE, ROICKOVO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

KOVO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KOVO.CA Yearly Profit, Operating, Gross MarginsKOVO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 -10 -20 -30 -40 -50

More info and screens

0

2. Health

2.1 Basic Checks

KOVO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KOVO has been increased compared to 1 year ago.
The debt/assets ratio for KOVO is higher compared to a year ago.
KOVO.CA Yearly Shares OutstandingKOVO.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
KOVO.CA Yearly Total Debt VS Total AssetsKOVO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -3.45, we must say that KOVO is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.45, KOVO is doing worse than 62.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.45
ROIC/WACCN/A
WACC7.45%
KOVO.CA Yearly LT Debt VS Equity VS FCFKOVO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M 4M -4M

2.3 Liquidity

A Current Ratio of 0.08 indicates that KOVO may have some problems paying its short term obligations.
With a Current ratio value of 0.08, KOVO is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.08 indicates that KOVO may have some problems paying its short term obligations.
KOVO has a worse Quick ratio (0.08) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
KOVO.CA Yearly Current Assets VS Current LiabilitesKOVO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 58.50% over the past year.
The Revenue has decreased by -0.58% in the past year.
The Revenue has been growing by 21.39% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)58.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.41%
Revenue 1Y (TTM)-0.58%
Revenue growth 3Y21.39%
Revenue growth 5YN/A
Sales Q2Q%4.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KOVO.CA Yearly Revenue VS EstimatesKOVO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KOVO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KOVO.CA Price Earnings VS Forward Price EarningsKOVO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KOVO.CA Per share dataKOVO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

KOVO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KOVO+ HOLDINGS INC

TSX-V:KOVO (10/29/2025, 7:00:00 PM)

0.04

+0 (+14.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-26 2025-08-26
Earnings (Next)11-25 2025-11-25
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners73.89%
Ins Owner ChangeN/A
Market Cap7.08M
Revenue(TTM)10.73M
Net Income(TTM)-5340000
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.47
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.09
BVpS-0.04
TBVpS-0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -46.9%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-35.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.11%
Cap/Sales 0.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -3.45
F-Score5
WACC7.45%
ROIC/WACCN/A
Cap/Depr(3y)41.45%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.58%
Revenue growth 3Y21.39%
Revenue growth 5YN/A
Sales Q2Q%4.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-259.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-455.65%
OCF growth 3YN/A
OCF growth 5YN/A

KOVO+ HOLDINGS INC / KOVO.CA FAQ

Can you provide the ChartMill fundamental rating for KOVO+ HOLDINGS INC?

ChartMill assigns a fundamental rating of 1 / 10 to KOVO.CA.


Can you provide the valuation status for KOVO+ HOLDINGS INC?

ChartMill assigns a valuation rating of 0 / 10 to KOVO+ HOLDINGS INC (KOVO.CA). This can be considered as Overvalued.


What is the profitability of KOVO stock?

KOVO+ HOLDINGS INC (KOVO.CA) has a profitability rating of 1 / 10.